EUVIMEDObjevte EUVIMED
VergleichsstudieOpen access · CC BY-NC 4.0

Impact of early corticosteroid withdrawal on simultaneous pancreas‐kidney transplant long‐term outcomes: Single center experience and comparison to the International Pancreas Transplant Registry

Dana R Pierce iD, Angelika Gruessner iD, Maya Campara iD, Pierpaolo DiCocco, Mario Spaggiari, Ivo Tzvetanov, Ignatius Tang, Enrico Benedetti, Alicia B Lichvar

Clinical Transplantation · 2023-10 · 37 (10)

DOI: 10.1111/ctr.15063 ↗

At a glance

Vergleichsstudie in Clinical Transplantation, 2023-07. Written by Dana R Pierce and 8 co-authors. Institution: Department of Pharmacy Practice, University of Illinois Chicago, Chicago, Illinois, USA. Major MEDLINE topics: Pancreas Transplantation, Kidney Transplantation, Graft Rejection, Registries. Cited 5 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

There remains a paucity of modern data comparing early steroid withdrawal (ESW) versus chronic corticosteroid (CCS) immunosuppression in simultaneous pancreas kidney (SPK) transplant recipients with long‐term follow‐up. Therefore, the purpose of this study is to assess the effectiveness and tolerability of ESW compared to CCS post‐SPK.

Methods

This was a retrospective single‐center matched comparison with the International Pancreas Transplant Registry (IPTR). Patients from University of Illinois Hospital (UIH) represented the ESW group and were compared to those matched CCS patients from the IPTR. Included patients were adult recipients of a primary SPK transplant between 2003 and 2018 within the US receiving rabbit anti‐thymocyte globulin induction. Patients were excluded if they had early technical failures, missing IPTR data, graft thrombosis, re‐transplant, or positive crossmatch SPK.

Results

A total of 156 patients were matched and included in the analysis. Patients were predominantly African American (46.15%) males (64.1%) with Type 1 diabetes etiology (92.31%). Overall pancreas allograft survival (hazard ratio [HR] = .89, 95% confidence interval [CI] .34–2.30, p = .81) and kidney allograft survival (HR = .80, 95%CI .32–2.03, p = .64) were similar between the two groups. Immunologic pancreas allograft loss was statistically similar at 1‐year (ESW 1.3% vs. CCS 0%, p = .16), 5‐year (ESW 1.3% vs. CCS 7.7%, p = .16), and 10‐year (ESW 11.0% vs. CCS 7.7%, p = .99). The 1‐year (ESW 2.6% vs. CCS 0%, p > .05), 5‐year (ESW 8.3% vs. CCS 7.0%, p > .05), and 10‐year (ESW 22.7% vs. CCS 9.9%, p = .2575) immunologic kidney allograft loss were also statistically similar. There was no difference in 10‐year overall patient survival (ESW 76.2% vs. CCS 65.6%, p = .63).

Conclusions

No differences were found between allograft or patient survival post‐SPK when comparing an ESW or CCS protocol. Future assessment is needed to determine differences in metabolic outcomes.

Subjects

MeSH terms (MEDLINE)

Pancreas TransplantationKidney TransplantationGraft RejectionRegistriesPostoperative ComplicationsImmunosuppressive AgentsAdrenal Cortex HormonesWithholding TreatmentHumansMaleFemaleRetrospective StudiesGraft SurvivalFollow-Up StudiesMiddle AgedPrognosisAdultRisk FactorsSurvival Rate

Author keywords

graft survivalimmunosuppressantimmunosuppressive regimensmaintenanceminimization/withdrawalsteroid

Substances

Immunosuppressive AgentsAdrenal Cortex Hormones

Authors and institutions

  • Department of Pharmacy Practice, University of Illinois Chicago, Chicago, Illinois, USA.
  • Department of Medicine/Nephrology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.
  • Department of Surgery, University of Illinois Chicago, Chicago, Illinois, USA.
  • Department of Nephrology, University of Illinois Chicago, Chicago, Illinois, USA.
  • Center for Transplantation, University of California San Diego Health, La Jolla, California, USA.

ORCID profiles: Dana R Pierce, Angelika Gruessner, Maya Campara

Cite

APA

Pierce, D. R., Gruessner, A., Campara, M., DiCocco, P., Spaggiari, M., Tzvetanov, I., Tang, I., Benedetti, E., & Lichvar, A. B. (2023). Impact of early corticosteroid withdrawal on simultaneous pancreas‐kidney transplant long‐term outcomes: Single center experience and comparison to the International Pancreas Transplant Registry. Clinical Transplantation, 37(10). https://doi.org/10.1111/ctr.15063

Vancouver

Pierce DR, Gruessner A, Campara M, DiCocco P, Spaggiari M, Tzvetanov I, et al. Impact of early corticosteroid withdrawal on simultaneous pancreas‐kidney transplant long‐term outcomes: Single center experience and comparison to the International Pancreas Transplant Registry. Clinical Transplantation. 2023;37(10). doi:10.1111/ctr.15063

BibTeX
@article{Pierce2023,
  author = {Pierce, Dana R and Gruessner, Angelika and Campara, Maya and DiCocco, Pierpaolo and Spaggiari, Mario and Tzvetanov, Ivo and Tang, Ignatius and Benedetti, Enrico and Lichvar, Alicia B},
  title = {Impact of early corticosteroid withdrawal on simultaneous pancreas‐kidney transplant long‐term outcomes: Single center experience and comparison to the International Pancreas Transplant Registry},
  journal = {Clinical Transplantation},
  year = {2023},
  volume = {37},
  number = {10},
  doi = {10.1111/ctr.15063}
}
Start for free →